亚太医疗器械市场 – 行业趋势及 2031 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

亚太医疗器械市场 – 行业趋势及 2031 年预测

  • Medical Devices
  • Upcoming Report
  • Jun 2024
  • Asia-Pacific
  • 350 页面
  • 桌子數: 220
  • 图号: 60

Asia Pacific Medical Devices Market

市场规模(十亿美元)

CAGR :  % Diagram

Diagram Forecast Period
2024 –2031
Diagram Market Size (Base Year)
USD 5.20 Billion
Diagram Market Size (Forecast Year)
USD 8.48 Billion
Diagram CAGR
%
Diagram Major Markets Players
  • Dummy1
  • Dummy2
  • Dummy3
  • Dummy4
  • Dummy5

>亚太医疗器械市场,按产品(重建关节置换、脊柱植入物、创伤和颅颌面、牙科植入物和骨科生物学)、设备类型(内固定设备和外固定设备)、生物材料(金属生物材料、聚合物生物材料、陶瓷生物材料、天然生物材料等)、程序(开放手术、微创手术 (MIS))、最终用户(医院、门诊护理中心、专科诊所、骨科中心等)划分——行业趋势和预测到 2031 年。

亚太医疗器械市场

 

亚太医疗器械市场分析及规模

亚太地区骨科植入物市场有望实现大幅增长,主要受几个关键因素推动。该地区人口众多且老龄化,骨关节炎、骨折和运动损伤等骨科疾病发病率不断上升,这些因素推动了对骨科植入物的需求。此外,医疗基础设施的改善、可支配收入的增加以及对先进治疗方案的认识不断提高,进一步推动了市场的增长。该市场为现有参与者和新进入者提供了丰厚的机遇,尤其是随着人们越来越注重开发创新且具有成本效益的植入物解决方案,以满足该地区特定的医疗需求。

2023 年亚太医疗器械市场规模价值 52 亿美元,预计到 2031 年将达到 84.8 亿美元,2024 年至 2031 年预测期内的复合年增长率为 6.30%。除了对市场价值、增长率、细分、地理覆盖范围和主要参与者等市场情景的见解外,Data Bridge Market Research 策划的市场报告还包括深度专家分析、患者流行病学、管道分析、定价分析和监管框架。

报告范围和市场细分       

报告指标

细节

预测期

2024 至 2031 年

基准年

2023

历史岁月

2022 (可定制为 2016-2021)

定量单位

收入(单位:十亿美元)、销量(单位:台)、定价(美元)

涵盖的领域

产品(重建关节置换、 脊柱植入物、创伤和颅颌面、牙科植入物和骨科生物制品)、设备类型(内固定装置和外固定装置)、生物材料(金属生物材料、聚合物生物材料、陶瓷生物材料、天然生物材料等)、程序(开放手术、微创手术 (MIS))、最终用户(医院、门诊护理中心、专科诊所、骨科中心等)

覆盖国家

中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾和亚太地区其他地区

涵盖的市场参与者

Zimmer Biomet (U.S.), Smith & Nephew plc (U.K.), Medtronic (Ireland), Stryker (U.S.), B. Braun SE (Germany), NuVasive, Inc. (U.S.), ENOVIS CORPORATION (U.S.), Institut Straumann AG (Switzerland), OSSTEM IMPLANT CO., LTD. (South Korea), Narang Medical Limited (U.S.), Globus Medical (U.S.), Arthrex, Inc. (U.S.), CONMED Corporation (U.S.), Integra LifeSciences Corporation (U.S.), RTI Surgical (U.S.), W. L. Gore & Associates, Inc. (U.S.), Corin Group (U.K.), and Johnson & Johnson Services, Inc. (U.S.)

Market Opportunities

  • Development of Innovative Implant Technologies  
  • Focus on Cost-Effective Solutions        

Market Definition

Orthopedic implants are medical devices designed to replace, support, or enhance the function of damaged or diseased bones and joints in the human body. These implants are typically used in surgical procedures to repair fractures, correct deformities, or replace joints affected by arthritis or other degenerative conditions. Common types of orthopedic implants include plates, screws, rods, pins, and prosthetic joints such as hip, knee, and shoulder replacements.                        

Medical Devices Market Dynamics

Drivers

  • Technological Advancements in Orthopedic Implant  

The Asia-Pacific region is witnessing rapid advancements in orthopedic implant technology, particularly in areas such as 3D printing, biocompatible materials, and minimally invasive surgical techniques. These advancements are revolutionizing the field of orthopedics by offering more precise, personalized, and effective implant solutions. Minimally invasive surgical techniques are also becoming more prevalent, leading to shorter recovery times, less scarring, and reduced post-operative pain for patients. These technological advancements are not only improving patient outcomes but also expanding the market for orthopedic implants by making procedures more accessible and efficient.        

  • Increasing Healthcare Spending

There is a greater willingness and ability among patients to seek advanced orthopedic treatments due to a significant increase in healthcare spending due to rising disposable incomes and improving healthcare infrastructure in countries such as China and India. This is driving the demand for orthopedic implants and related services in the region. Furthermore, the increasing focus on preventive healthcare and early intervention is motivating individuals to seek treatment for orthopedic conditions at an earlier stage, further boosting the market for orthopedic implants.

Opportunities

  • Development of Innovative Implant Technologies  

The design of implants tailored for Asian anatomies, which may differ from Western anatomies in terms of bone structure and size, is one key area of focus. By developing implants that better match the anatomical characteristics of Asian patients, manufacturers can improve surgical outcomes and patient satisfaction. There is a push towards incorporating advanced materials and technologies, such as biodegradable implants and smart implants with integrated sensors, to enhance implant functionality and longevity. The development of innovative orthopedic implant technologies customized to meet the specific needs and preferences of its diverse population presents a growing opportunity for the market.         

  • Focus on Cost-Effective Solutions 

Through the optimization of manufacturing processes, utilization of cost-effective materials, and streamlining of distribution channels, manufacturers can offer orthopedic implants at lower price points without compromising on quality. Furthermore, partnerships with healthcare providers and government agencies to establish reimbursement schemes and subsidy programs for orthopedic implants can further enhance affordability and accessibility for patients. This growing demand for cost-effective orthopedic implant solutions in the Asia-Pacific region is creating opportunities for manufacturers.

Restraints/Challenges

  • High Cost of Implants      

The cost of these implants can be prohibitive for many patients, leading to delayed or inadequate treatment. Factors contributing to the high cost include the use of premium materials, sophisticated manufacturing processes, and the need for specialized expertise in implantation procedures. The high cost of orthopedic implants, especially those incorporating advanced technologies, poses a significant barrier to access for patients in lower-income countries across the Asia-Pacific region.    

  • Limited Reimbursement Policies 

Inadequate reimbursement can restrict access to advanced implant technologies and limit treatment options for patients. Healthcare providers may be reluctant to recommend expensive implants if they are not reimbursed adequately, leading to suboptimal patient care. Limited or inconsistent reimbursement policies for orthopedic implants in some countries within the Asia-Pacific region present a challenge for both patients and healthcare providers.

本市场报告详细介绍了最新发展、贸易法规、进出口分析、生产分析、价值链优化、市场份额、国内和本地市场参与者的影响,分析了新兴收入领域的机会、市场法规的变化、战略市场增长分析、市场规模、类别市场增长、应用领域和主导地位、产品批准、产品发布、地域扩展、市场技术创新。如需获取更多市场信息,请联系 Data Bridge Market Research 获取分析师简报,我们的团队将帮助您做出明智的市场决策,实现市场增长。

最新动态

  • 2022 年 11 月,Equinix, Inc. 和 VMware, Inc. 扩大了合作,推出了 VMware Cloud on Equinix Metal,通过分布式云服务提高了企业应用程序的性能、安全性和成本效益。这一发展可以确保医疗保健应用程序拥有强大而安全的数字基础设施,从而使骨科植入物市场受益
  • 2022 年 9 月,Arm Ltd 推出 Neoverse V2,满足了不断增长的数据需求,可能使骨科植入物市场受益。这项芯片技术进步支持满足医疗保健需求的数据中心,满足骨科手术和治疗日益增长的技术要求
  • 2022 年 3 月,Elea Digital 与 Vertiv 在巴西合作提供边缘数据中心服务,确保高效的关键基础设施管理。此次合作可能通过增强整体医疗数据处理基础设施,确保无缝访问骨科手术患者信息,为骨科植入物市场做出贡献

医疗器械市场范围

市场根据产品、设备类型、生物材料、程序和最终用户进行细分。这些细分市场之间的增长情况将帮助您分析行业中增长缓慢的细分市场,并为用户提供有价值的市场概览和市场洞察,帮助他们做出战略决策,确定核心市场应用。

产品

  • 重建关节置换
  • 脊柱植入物
  • 创伤和颅颌面
  • 牙科植入物
  • 骨科生物学

设备类型

  • 内固定装置
  • 外部固定装置

生物材料

  • 金属生物材料
  • 高分子生物材料
  • 陶瓷生物材料
  • 天然生物材料
  • 其他的

过程

  • 开放手术
  • 微创手术(MIS)

最终用户

  • 医院
  • 门诊护理中心
  • 专科诊所
  • 骨科中心
  • 其他的

医疗器械市场区域分析/见解

对市场进行了分析,并按国家、产品、设备类型、生物材料、程序和最终用户提供了市场规模洞察和趋势,如上所述。

该市场覆盖的国家包括中国、日本、印度、韩国、新加坡、马来西亚、澳大利亚、泰国、印度尼西亚、菲律宾和亚太其他国家。

由于对重建关节置换的需求,中国有望主导市场。随着人口老龄化,关节置换的需求不断增长,与年龄相关的骨科疾病患病率不断上升,这凸显了中国在市场上的主导地位。 

由于印度肌肉骨骼和骨科损伤发生率不断上升,预计预测期内印度将出现显著增长,从而推动对骨科植入手术的需求。

报告的国家部分还提供了影响单个市场因素和国内市场监管变化,这些因素和变化影响了市场的当前和未来趋势。下游和上游价值链分析、技术趋势和波特五力分析、案例研究等数据点是用于预测单个国家市场情景的一些指标。此外,在提供国家数据的预测分析时,还考虑了亚太品牌的存在和可用性以及它们因来自本地和国内品牌的激烈或稀缺竞争而面临的挑战、国内关税和贸易路线的影响。

医疗保健基础设施增长安装基础和新技术渗透

该市场还为您提供每个国家/地区资本设备医疗支出增长、市场上不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗监管情景的变化及其对市场的影响的详细市场分析。数据适用于 2016-2021 年的历史时期。

竞争格局和医疗器械市场份额分析

市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、产生的收入、市场潜力、研发投资、新市场计划、亚太地区业务、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对市场的关注有关。

市场上的一些主要参与者包括:

  • Zimmer Biomet(美国)
  • Smith & Nephew plc(英国)
  • 美敦力(爱尔兰)
  • 史赛克(美国)
  • B. Braun SE(德国)
  • NuVasive, Inc.(美国)
  • ENOVIS 公司(美国)
  • Institut Straumann AG(瑞士)
  • OSSTEM IMPLANT CO., LTD.(韩国)
  • Narang Medical Limited(美国)
  • Globus Medical(美国)
  • Arthrex, Inc.(美国)
  • CONMED 公司 (美国)
  • Integra LifeSciences Corporation(美国)
  • RTI 外科 (美国)
  • 戈尔公司 (美国)
  • Corin 集团 (英国)
  • 强生服务公司(美国)


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Asia-Pacific Medical Devices Market size will be worth USD 8.48 billion by 2031.
The Asia-Pacific Medical Devices Market growth rate will be 6.30% by 2031
The Increasing Healthcare Spending and Technological Advancements in Orthopedic Implant are the growth drivers of the Asia-Pacific Medical Devices Market.
The products, device type, biomaterial, procedures, and end users are the factors on which the Asia-Pacific Medical Devices Market research is based.
The major companies in the Asia-Pacific Medical Devices Market are Zimmer Biomet (U.S.), Smith & Nephew plc (U.K.), Medtronic (Ireland), Stryker (U.S.), B. Braun SE (Germany), NuVasive, Inc. (U.S.), ENOVIS CORPORATION (U.S.), Institut Straumann AG (Switzerland), OSSTEM IMPLANT CO., LTD. (South Korea), Narang Medical Limited (U.S.), Globus Medical (U.S.), Arthrex, Inc. (U.S.), etc.